Pennant Group (PNTG) Revenue & Revenue Breakdown
Pennant Group Revenue Highlights
Latest Revenue (Y)
$695.24M
Latest Revenue (Q)
$209.84M
Main Segment (Y)
Home Health And Hospice Services Segment
Pennant Group Revenue by Period
Pennant Group Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $695.24M | 27.59% |
| 2023-12-31 | $544.89M | 15.14% |
| 2022-12-31 | $473.24M | 7.63% |
| 2021-12-31 | $439.69M | 12.47% |
| 2020-12-31 | $390.95M | 15.49% |
| 2019-12-31 | $338.53M | 18.34% |
| 2018-12-31 | $286.06M | 13.97% |
| 2017-12-31 | $250.99M | 15.54% |
| 2016-12-31 | $217.22M | - |
Pennant Group generated $695.24M in revenue during NA 2024, up 27.59% compared to the previous quarter, and up 205.37% compared to the same period a year ago.
Pennant Group Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $209.84M | 11.09% |
| 2024-12-31 | $188.89M | 4.54% |
| 2024-09-30 | $180.69M | 7.08% |
| 2024-06-30 | $168.75M | 7.54% |
| 2024-03-31 | $156.91M | 7.51% |
| 2023-12-31 | $145.95M | 4.11% |
| 2023-09-30 | $140.19M | 5.98% |
| 2023-06-30 | $132.28M | 4.60% |
| 2023-03-31 | $126.46M | 1.44% |
| 2022-12-31 | $124.67M | 5.34% |
| 2022-09-30 | $118.35M | 1.75% |
| 2022-06-30 | $116.32M | 2.11% |
| 2022-03-31 | $113.91M | 1.92% |
| 2021-12-31 | $111.77M | -0.14% |
| 2021-09-30 | $111.92M | 1.43% |
| 2021-06-30 | $110.34M | 4.43% |
| 2021-03-31 | $105.66M | -2.13% |
| 2020-12-31 | $107.97M | 9.73% |
| 2020-09-30 | $98.40M | 6.10% |
| 2020-06-30 | $92.74M | 0.97% |
| 2020-03-31 | $91.85M | 2.63% |
| 2019-12-31 | $89.49M | 1.24% |
| 2019-09-30 | $88.40M | 6.85% |
| 2019-06-30 | $82.73M | 6.20% |
| 2019-03-31 | $77.91M | 3.41% |
| 2018-12-31 | $75.34M | 3.27% |
| 2018-09-30 | $72.95M | 4.53% |
| 2018-06-30 | $69.79M | 2.66% |
| 2018-03-31 | $67.98M | - |
Pennant Group generated $209.84M in revenue during Q1 2025, up 11.09% compared to the previous quarter, and up 143.77% compared to the same period a year ago.
Pennant Group Revenue Breakdown
Pennant Group Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Home Health And Hospice Services Segment | $515.34M | $394.46M | $342.25M | $309.57M | $253.66M |
| Senior Living Services Segment | $175.76M | $150.43M | $130.99M | $130.12M | $137.29M |
Pennant Group's latest annual revenue breakdown by segment (product or service), as of Dec 24: Home Health And Hospice Services Segment (74.57%), and Senior Living Services Segment (25.43%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Home Health And Hospice Services Segment | $165.25M | $159.44M | $263.18M | $135.67M | $116.49M | $106.89M | $101.47M | $95.02M | $91.08M | $90.65M | $85.78M | $85.34M | $80.47M | $77.86M | $79.00M | $78.11M | $74.61M | $74.53M | $64.38M | $57.98M |
| Senior Living Services Segment | $53.48M | $49.97M | $90.31M | $45.02M | $40.42M | $39.06M | $38.72M | $37.26M | $35.38M | $34.01M | $32.57M | $30.97M | $33.44M | $33.91M | $32.92M | $32.24M | $31.06M | $33.43M | $34.02M | $34.76M |
Pennant Group's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Home Health And Hospice Services Segment (75.55%), and Senior Living Services Segment (24.45%).
Pennant Group Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CRMD | CorMedix | $43.47B | $39.08M |
| AMN | AMN Healthcare Services | $2.98B | $689.53M |
| EVH | Evolent Health | $2.55B | $444.33M |
| EMBC | Embecta | $1.12B | $259.00M |
| INNV | InnovAge | $853.70M | $209.00M |
| PNTG | Pennant Group | $695.24M | $209.84M |
| CDNA | CareDx | $333.79M | $84.69M |
| SNDA | Sonida Senior Living | $304.33M | $93.53M |
| HSTM | HealthStream | $291.65M | $74.40M |
| DNA | Ginkgo Bioworks | $227.04M | $48.32M |
| VIR | Vir Bio | $74.20M | $1.21M |